Skip to main content
THE BioMed Co., Ltd. logo

THE BioMed Co., Ltd. — Investor Relations & Filings

Ticker · 214610 ISIN · KR7214610008 KO Manufacturing
Open in API
Filings indexed 447 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 214610

About THE BioMed Co., Ltd.

https://www.biomed.co.th/english/

BIOMEDCO is a pharmaceutical company that specializes exclusively in the development and supply of high-grade intravenous (IV) injections. The company is committed to providing reliable pharmaceutical products for medical applications.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is a Korean Quarterly Report (“분기보고서”) for the period 2026.01.01–2026.03.31 (제18기). It contains detailed corporate information, capital changes, shareholding tables, subsidiary lists, and other substantive interim financial data and disclosures – not merely an announcement or link to a report. This matches the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 85% confidence The document is a Korean-language notice of convocation (“주주총회소집결의”) for an extraordinary shareholders’ meeting, including a date change correction. It does not contain meeting materials or proxy statements, nor is it a financial or legal report, dividend notice, M&A announcement, or other specific category. It is a standard regulatory announcement of convening a shareholders’ meeting, best mapped to the fallback “Regulatory Filings” category (RNS).
2026-04-29 Korean
금전대여결정
Capital/Financing Update Classification · 80% confidence The document is a regulatory disclosure of a corporate loan decision (“금전대여 결정”) describing the company’s financing activity—loan amount, interest rate, duration, collateral and board resolution details. It is not an annual or interim report, and is not about share issues or dividends. This fits under Capital/Financing Update (CAP) as it details a financing transaction.
2026-04-13 Korean
기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)
Delisting Announcement Classification · 95% confidence The document is an official notice (‘기타시장안내’) regarding a delisting process for the company, detailing the submission of an objection to the delisting and the grant of an improvement period by the exchange. It is not a full financial report but a regulatory announcement about the company’s delisting status. This matches the “Delisting Announcement” category.
2026-04-10 Korean
주권매매거래정지기간변경 (개선기간 부여)
Regulatory Filings Classification · 65% confidence The document is a short exchange notice in Korean regarding a change in the trading suspension period for a listed security (“주권매매거래정지 기간변경”) under KOSDAQ listing rules. It’s not a financial report (10-K, IR, ER, etc.), not a management announcement, and not a dividend or governance statement. It’s a miscellaneous regulatory announcement about trading suspension procedures, so it falls into the generic “Regulatory Filings” category.
2026-04-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 45% confidence The document is a short regulatory announcement in Korean setting the shareholder register closure period (record date) for an extraordinary general meeting. This is not a financial report, proxy statement, or dividend notice, but rather a corporate action notice. It therefore falls under the fallback Regulatory Filings category (RNS).
2026-04-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.